European Lithium's Takeover Math Tightens as Greenland Jitters Meet an Austrian Permit Hurdle

European Lithium's $835M merger with Critical Metals faces delay to Nov 2026; CRML near floor boosts exchange ratio, but Wolfsberg permit uncertainty persists.

The path to European Lithium's NASDAQ debut is getting longer — and more intricate. The Perth-based explorer has now filed its formal explanatory statement with Australia's corporate regulator, ASIC, a mandatory checkpoint on the road to the court-approved scheme of arrangement that would see Critical Metals Corp absorb all of European Lithium's issued share capital and listed options. The all-stock transaction carries a price tag of US$835 million.

Investors tracking the deal have been handed the document that will underpin the scheme meeting and, eventually, the court hearing in Western Australia. But the timeline has stretched: implementation is now slated for early November 2026, several weeks later than the September-October window originally projected.

A Floating Formula Replaces the Fixed Ratio

At the heart of the deal sits a reworked exchange structure agreed in mid-August. The original fixed ratio of 0.035 CRML shares per European Lithium share has been scrapped in favour of a variable band between 0.025 and 0.045, calculated off a 20-day volume-weighted average price of Critical Metals Corp on the Nasdaq. A floor of US$8.00 and a ceiling of US$16.00 bracket the range, shielding both parties from violent swings before closing.

That protective collar is now being tested. Critical Metals shares slipped 5.1 percent to US$7.63 — perilously close to the lower boundary. Media reports point to execution risks and possible delays at the Tanbreez rare earths project in Greenland as the culprit, injecting fresh volatility into the fusion partner's stock just as the exchange ratio's sensitivity peaks.

The mechanics cut both ways: with CRML trading near the floor, the conversion ratio would land at the top of its band — 0.045 CRML shares per European Lithium share — a dynamic that helps explain the recent price action in both listings without any disruption to the deal's underlying schedule.

Wolfsberg's Shadow Lengthens

While the merger machinery grinds forward, European Lithium's core asset remains in limbo. A final investment decision on the Wolfsberg lithium project in Austria won't come before late 2026, at the earliest. The holdup stems from an Austrian federal court ruling late last year that annulled a key environmental permit — without that approval restored, the project lacks the legal foundation for a green light.

That regulatory overhang has quietly reshaped how the market values the company. European Lithium's 31 percent stake in Critical Metals — 45,536,338 shares, valued at roughly US$303.3 million based on the August 14 close — now carries more weight in the share price than any operational progress in the Austrian Alps.

Market Reaction: A 45 Percent Month, Then a Pullback

The stock closed Friday at €0.2235, down 3.2 percent on the day — a dip that coincided with Critical Metals' slide, underscoring how tightly the two listings now move in tandem. The short-term picture, however, remains buoyant: European Lithium is up 1.1 percent on the week and a hefty 45 percent over the past 30 days.

The longer view is even more striking. Year-to-date, the shares have gained 147 percent, and over twelve months they've climbed 317 percent. Even with Friday's setback, the stock trades roughly 30 percent above its 200-day moving average — though it sits 27 percent below the 52-week high of €0.3055 touched in early June.

The procedural calendar now points to a September 15 hearing before the Supreme Court of Western Australia, where the company will seek orders to convene separate meetings of shareholders and option holders. Those votes, the ASIC sign-off, and the court's final blessing all precede the November closing. For holders, the near-term catalyst remains the Nasdaq tape: as long as CRML hovers near its floor, the exchange ratio tilts in European Lithium's favour — even as the wait for both the merger and Wolfsberg's fate stretches on.